Cargando…

Mirabegron: a decade of study

Detalles Bibliográficos
Autor principal:	Welk, Blayne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658132/ https://www.ncbi.nlm.nih.gov/pubmed/33209695 http://dx.doi.org/10.21037/tau-20-844

Ejemplares similares

Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo
por: Scandura, Carmen, et al.
Publicado: (2020)

Editorial commentary on “Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo”
por: Yamanishi, Tomonori, et al.
Publicado: (2020)

Laser devices for vaginal rejuvenation: effectiveness, regulation and marketing
por: Welk, Blayne, et al.
Publicado: (2023)

Editorial comment: Cross-cultural adaptation and validation of the neurogenic bladder symptom score questionnaire for brazilian portuguese
por: Welk, Blayne
Publicado: (2019)

Body‐weight‐independent glucose‐lowering effect of the β3‐adrenergic receptor agonist mirabegron in humans
por: Waki, Hironori, et al.
Publicado: (2021)

Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice
por: Kim, Seo-Yeon, et al.
Publicado: (2023)

Home care in respiratory therapy
por: Clarke, Blayne T
Publicado: (2016)

Patient reported outcome measures in neurogenic bladder
por: Clark, Roderick, et al.
Publicado: (2016)

Does COVID-19 infection change the need for future surgical interventions? An exploratory analysis.
por: Welk, Blayne, et al.
Publicado: (2021)

Instruments au laser pour rajeunissement vaginal : efficacité, réglementation et commercialisation
por: Welk, Blayne, et al.
Publicado: (2023)

Inaccuracies in the recently published review on mirabegron
por: Siddiqui, Emad
Publicado: (2013)

Mirabegron in the Management of Overactive Bladder Syndrome
por: O’Kane, Miriam, et al.
Publicado: (2022)

Decade of the Mind
por: Spitzer, Manfred
Publicado: (2008)

Revisiting current treatment options for stress urinary incontinence and pelvic organ prolapse: a contemporary literature review
por: Wu, You (Maria), et al.
Publicado: (2019)

Editorial Comment: An Effective Evidence-Based Cleaning Method for the Safe Reuse of Intermittent Urinary Catheters: In Vitro Testing
por: Averbeck, Marcio Augusto, et al.
Publicado: (2020)

Serum sickness–like reaction associated with mirabegron
por: Tan, Marcus G., et al.
Publicado: (2019)

Distinct Conformations of Mirabegron Determined by MicroED
por: Lin, Jieye, et al.
Publicado: (2023)

IPNA–ESPN Junior Master Class—a decade of successful continuing education and training in pediatric nephrology
por: Teixeira, Ana, et al.
Publicado: (2023)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

Internal and External Barriers to Bladder Management in Persons with Neurologic Disease Performing Intermittent Catheterization
por: Herbert, Amber S., et al.
Publicado: (2023)

disease biology in the coming decade(s)
por: Rao, M.R.S.
Publicado: (2012)

Business alignment for the “Decade of Action”
por: Sachs, Jeffrey D., et al.
Publicado: (2021)

Patient utilization survey of mirabegron prescribed for overactive bladder
por: Rahkola-Soisalo, Päivi, et al.
Publicado: (2019)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
por: Sharaf, Ala’a, et al.
Publicado: (2017)

Mirabegron: The most promising adipose tissue beiging agent
por: Bel, Jocelyn S., et al.
Publicado: (2021)

The combined effect of metformin and mirabegron on diet‐induced obesity
por: Zhao, Xin‐Yuan, et al.
Publicado: (2023)

The use of urologic investigations among patients with traumatic spinal cord injuries
por: Welk, Blayne, et al.
Publicado: (2016)

The requirement for surgery and subsequent 30-day mortality in patients with COVID-19
por: Welk, Blayne, et al.
Publicado: (2021)

The first decade of antiretroviral therapy in Africa
por: Ford, Nathan, et al.
Publicado: (2011)

Commentary - Radiology in India: The Next Decade
por: Ragavan, Dhandhapany
Publicado: (2008)

Commentary - Radiology in India: The Next Decade
por: Kalyanpur, Arjun
Publicado: (2008)

Commentary - Radiology in India: The Next Decade
por: Jankharia, Govindji R.
Publicado: (2008)

Respiratory dysfunction following initiation of mirabegron: A case report
por: Malsin, Elizabeth S., et al.
Publicado: (2019)

Five-year plans and once-in-a-decade interventions: Need to move from filling gaps to bridging chasms in mental health care in India
por: Murthy, Pratima, et al.
Publicado: (2016)

Large cell acanthoma: a debate throughout the decades
por: Patsatsi, Aikaterini, et al.
Publicado: (2014)

A decade of the hostile environment and its impact on health
por: Essex, Ryan, et al.
Publicado: (2022)

A phase II dose-ranging study of mirabegron in patients with overactive bladder
por: Chapple, Christopher R., et al.
Publicado: (2013)

Association of Virtual Care Expansion With Environmental Sustainability and Reduced Patient Costs During the COVID-19 Pandemic in Ontario, Canada
por: Welk, Blayne, et al.
Publicado: (2022)

The metabolic effects of mirabegron are mediated primarily by β(3)‐adrenoceptors
por: Dehvari, Nodi, et al.
Publicado: (2020)

The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
por: Gubbiotti, Marilena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k6j2m7ano0agabpmen1bogbd02